Democratic Senators Demand Information on Telehealth Provider Affiliations with Eli Lilly and Pfizer

April 9, 2025

EGWP marketplace medicaid Medicare

Four Democratic senators sent a letter to five telehealth companies that have held contracts with Pfizer and Eli Lilly, inquiring about their financial relationships and possible influence on prescriptions for medications. The letter was signed by the ranking member of the Senate Judiciary Committee and member of Senate Democratic leadership, Sen. Dick Durbin (D-IL), and the ranking member of the Senate Health, Education, Labor and Pensions (HELP) Committee, Sen. Bernie Sanders (I-VT), as well as Sens. Peter Welch (D-VT) and Elizabeth Warren (D-MA).

The letter accuses these arrangements of sending direct-to-consumer advertisements that steer patients toward particular medications and create the potential for inappropriate prescribing that can increase health care spending. The letters were addressed to the CEOs of 9amHealth, Thirty Madison (Cove), Form Health, Populus Health Technologies, and UpScriptHealth, and demand answers to questions by April 15.

Initiatives

Calls grow for Drug Patent reform

In a recent blog post, the Pharmaceutical Care Management Association (PCMA) highlighted increased attention to pharmaceutical companies’ abuse of drug patents. Last month, the Supreme Court unanimously ruled in favor of a generic drugmaker in a “skinny labeling” case, a victory for patients. Skinny labels allow generic and biosimilar competitors to launch products for non-patented indications, helping accelerate […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

perspectives

AHIP calls for Bipartisan reform to address health care cost drivers

On July 23, AHIP President and CEO Mike Tuffin wrote an opinion piece in The New York Times saying, “common-sense bipartisan reforms are needed to promote competition in care delivery and prescription drugs, protect consumers from providers and drugmakers’ anticompetitive practices and transition away from the perverse incentives of fee-for-service medicine.” Tuffin notes that health […]
read more >

August 11, 2026

EGWP marketplace medicaid Medicare

Solutions

PCMA urges preserving patient access and flexibility in new fertility benefits rule

PCMA recently submitted comments to HHS, DOL, and the Treasury (the Departments) in response to the proposed rule establishing a new category of limited excepted benefits for fertility services. PCMA supports the Departments’ goal of expanding access to fertility care while encouraging employer innovation but urged several targeted refinements to ensure the framework is operationally […]
read more >

August 11, 2026

marketplace medicaid

You may also like